RecruitingNot ApplicableNCT02812212

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

Cortical Transit Time on Diuretic Renogram as an Early Marker of Significant Obstruction in Antenatally Detected Uretero-pelvic Junction Syndrome


Sponsor

Centre Hospitalier Universitaire de la Réunion

Enrollment

75 participants

Start Date

Nov 28, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome


Eligibility

Min Age: 4 WeeksMax Age: 8 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called diuretic renography and a medical device called ultrasonography for people with ureteropelvic junction obstruction. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 4 Weeks to 8 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEultrasonography

bilateral ultrasonography to measure the antero-posterior renal pelvic diameter (APRPD) in both positions.

DEVICEdiuretic renography

diuretic renography to measure the cortical transit time.


Locations(5)

CHU de Bordeaux

Bordeaux, France

CHU de Limoges

Limoges, France

CHU de Nantes

Nantes, France

CHU de Rennes

Rennes, France

Centre Hospitalier Universitaire de La Réunion

Saint-Denis, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02812212


Related Trials